Roche and Sysmex Expand Long-Term Alliance
Pharmaceutical group Roche and Japanese diagnostics company Sysmex are expanding and extending their existing long-standing partnership. Under the renewed terms of the non-inclusive agreement, Roche will continue to offer Sysmex's hematology products, which complement the company's laboratory solutions portfolio, they said in a statement yesterday.
The updated non-exclusive agreement also includes an additional eco-social agreement to jointly explore more sustainable diagnostic solutions, the partners said. The two companies had already been working together for 25 years.
“We are delighted to expand our 25-year partnership with Sysmex in the area of hematology and in exploring more sustainable diagnostics solutions. Roche and Sysmex both have a long-standing history of delivering reliable and innovative solutions for patients and I am very happy to see this collaboration grow,” said Matt Sause, CEO of Roche Diagnostics.
“We are pleased to announce the renewal of our partnership with Roche, reaffirming our commitment to long-term collaboration. Developing our partnerships in the field of diagnostics even further and addressing enduring eco-social challenges represents a significant milestone in advancing our alliance to the next level. Together, we firmly believe in making even greater contributions to our customers in laboratories and creating a sustainable society,” said Kaoru Asano, president of Sysmex.
Roche and Sysmex started their commercial and R&D collaboration in 1998 and continuously expanded their partnership. In 2020, the two companies signed an agreement to further expand their partnership and to improve customer experience.
